Bend Bioscience has announced the installation of new equipment at its 120,000-square-foot Gainesville, Georgia facility, strengthening its pharmaceutical services and manufacturing capabilities. The addition includes a GEA PSD-4 spray dryer and a Gerteis dry granulation system, which will enhance absorption and
CoreRx, Societal CDMO, and Bend Bioscience have officially merged under the Bend Bioscience brand, forming a fully integrated contract development and manufacturing organization (CDMO). This merger combines the distinct strengths of all three companies to offer an extensive range of
QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and Societal. Murray, who most recently served as CEO of Aprecia Pharmaceutical, brings over 25 years
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
